Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Interest & Investment Income: 2024-2025

Historic Interest & Investment Income for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $6.3 million.

  • Kura Oncology's Interest & Investment Income rose 6.48% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.7 million, marking a year-over-year change of. This contributed to the annual value of $22.8 million for FY2024, which is 55.20% up from last year.
  • Latest data reveals that Kura Oncology reported Interest & Investment Income of $6.3 million as of Q3 2025, which was down 9.53% from $6.9 million recorded in Q2 2025.
  • Kura Oncology's 5-year Interest & Investment Income high stood at $7.9 million for Q1 2025, and its period low was $5.3 million during Q1 2024.
  • Moreover, its 2-year median value for Interest & Investment Income was $6.0 million (2024), whereas its average is $6.3 million.
  • Data for Kura Oncology's Interest & Investment Income shows a peak YoY skyrocketed of 47.96% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Kura Oncology's Interest & Investment Income stood at $5.7 million in 2024, then increased by 6.48% to $6.3 million in 2025.
  • Its last three reported values are $6.3 million in Q3 2025, $6.9 million for Q2 2025, and $7.9 million during Q1 2025.